NCT04623242: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
- State
- Completed
- Phase
- Phase 2 and Phase 3
- People
- 194 taking part
- Started
- Dec 2012
- Primary completion
- 22 Nov 2019
- Arms
- Gantenerumab
- Results
- Posted on the registry
- Papers
- doi:10.1001/jamaneurol.2024.0991, doi:10.1136/bmjno-2022-000335
- 6 Mar 2020: Trial completed
- 10 Nov 2020: Trial registered
- 22 Sep 2022: Trial results posted